StreetAlpha.app
Home › Stocks › FTRE

Fortrea Holdings Inc. (FTRE)

Healthcare
$19.59
▼ −1.01%
LAST CLOSE · NOV 17

Fortrea provides clinical trial and drug development services to pharmaceutical, biotechnology and medical device companies. It last closed at $19.59 on Nov 17, down 1.01% on the day. The average 12-month price target from 7 analysts is $26.14 (+33.5% from the last close), with a high of $29.00 and a low of $22.00. Analyst consensus is Strong Buy, based on the latest ratings from 7 firms (6 buy, 1 hold, 0 sell).

AI Auto Pilots
Is FTRE in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.7B
−3.4% vs a year ago
Net income
−$68.7M
−2.6% margin
EPS (diluted)
−$0.66
Free cash flow
$169.0M
6.3% margin
Valuation
Market cap
$1.9B
96.5M shares
P/E
–
No P/E while losing money
Price to sales
0.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$220.6M
At Sep 30
Debt
$1.1B
At Sep 30
Shareholder equity
$532.3M
Shares outstanding
96.5M
At Oct 27
Employees19,000 (Sep 30, 2023)
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $3.1B$3.1BFY2021FY2022: $2.8B$2.8BFY2022FY2023: $2.8B$2.8BFY2023FY2024: $2.7B$2.7BFY2024FY2025: $2.7B$2.7BFY2025

From FTRE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
—
No date on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Strong Buy
Based on 7 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
7firms
6 Buy1 Hold0 Sell
Each firm's latest rating on FTRE in the past 90 days
Average 12-month target
$26.14
▲ 33.5% upside

Based on 7 analysts who set a price target on FTRE in the past 90 days. The average target is $26.14, with a high of $29.00 and a low of $22.00, compared with the last close of $19.59.

Low $22.00Avg $26.14High $29.00
Blue marker: last close $19.59
Highest target$29.00
Average target$26.14
Lowest target$22.00
Latest rating changes
TD CowenTarget raised
Nov 2Buy$23 → $26
CitigroupMaintained
Oct 30Buy$27
Truist SecuritiesTarget raised
Oct 30Buy$26 → $29
BarclaysTarget raised
Oct 30Buy$23 → $26
Evercore ISI GroupMaintained
Oct 30Buy$28
DateFirmActionRatingPrice target
Nov 2TD CowenTarget raisedBuy$23 → $26
Oct 30CitigroupMaintainedBuy$27
Oct 30Truist SecuritiesTarget raisedBuy$26 → $29
Oct 30BarclaysTarget raisedBuy$23 → $26
Oct 30Evercore ISI GroupMaintainedBuy$28
Loading…

Technical Analysis

FTRE · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 12% below its 20 day and 6% below its 50 day average. It is 19% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the 100 day average at $19.57, and the nearest resistance the swing high (Aug 5) at $19.72.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 7.0%/day
Key levels
$26.1652 week high+33.5%
$21.9020 day average+11.8%
$20.8650 day average+6.5%
$20.34Pivot R1+3.8%
$19.80Pivot+1.1%
$19.72Swing high (Aug 5)+0.7%
$19.59Last close
$19.57100 day average−0.1%
$19.25Swing low (Sep 24)−1.7%
$19.06Pivot S1−2.7%
$15.93200 day average−18.7%
$8.5552 week low−56.4%
Indicators
RSI (14)40.66Middle of its rangeNeutral
MACD-0.39Below its signal lineBearish
Stochastic13.8Near the bottom of its rangeOversold
ADX (14)22.4Weak trend
Williams %R-87.1Oversold below −80, overbought above −20Oversold
CCI (20)-90.5Oversold below −100, overbought above 100Neutral
Rate of change−6.5%Change over 10 sessionsBearish
ATR (14)$1.36Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for FTRE

What happened before

See how FTRE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow FTRE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How FTRE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in FTRE in the last 90 days.

Loading…

See today’s whale options flow across the market →

FTRE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ●149 buying vs 140 selling
  • ▲Held by funds +2.8 pts
  • ▲Funds holding +12
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding348336+3.6%
In funds' top 1010–
Held by funds106.7%103.9%+2.8 pts
New / increased48 / 10142 / 100+4.9%
Reduced / sold out106 / 34109 / 38−4.8%
Put/call ratio0.000.01−100.0%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See FTRE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FTRE is in one of them and how their past FTRE trades turned out.

FTRE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered FTRE in an article yet. Here's the latest on the wider market.

FTRE Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Sep 22
Who traded FTRE · since 2025
Latest 3 filings
$15K – $50KTraded Jul 29, 2026Filed Sep 22, 2026
$1K – $15KTraded Jun 23, 2025Filed Jul 25, 2025
$1K – $15KTraded Jun 23, 2025Filed Jul 24, 2025
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$15K – $50KJul 29, 2026Sep 22, 202655 d
French HillHouseSell$1K – $15KJun 23, 2025Jul 25, 202532 d
James French HillR · ARSell$1K – $15KJun 23, 2025Jul 24, 202531 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Fortrea Holdings

Fortrea is a contract research organization based in Durham, North Carolina. It provides clinical trial and development services to pharmaceutical, biotechnology and medical device companies. Its offerings include clinical pharmacology studies, full clinical development from early phase through trials after approval, and consulting on product development, regulatory strategy and market access. Customers can choose full service, functional service provider or hybrid delivery models.

Headquarters
Durham, NC